R Eberl
Impact in
- Rheumatology top 10%
- Rheumatoid Arthritis Research and Therapies
- Spondyloarthritis Studies and Treatments
- Systemic Lupus Erythematosus Research
- Osteoarthritis Treatment and Mechanisms
- Immunology and Allergy top 10%
- Cell Adhesion Molecules Research
Papers in
- Rheumatology 25
- Rheumatoid Arthritis Research and Therapies 16
- Urticaria and Related Conditions 5
- Spondyloarthritis Studies and Treatments 4
- Systemic Lupus Erythematosus Research 4
- Pharmacology 13
- Inflammatory mediators and NSAID effects 8
- Drug-Induced Adverse Reactions 4
R Eberl
61 papers receiving 270 citations
Peers
Comparison fields: 5 of 79
- Rheumatology 108
- Immunology and Allergy 43
- Pharmacology 75
- Immunology 58
- Molecular Medicine 13
Countries citing papers authored by R Eberl
This map shows the geographic impact of R Eberl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R Eberl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R Eberl more than expected).
Fields of papers citing papers by R Eberl
This network shows the impact of papers produced by R Eberl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R Eberl. The network helps show where R Eberl may publish in the future.
Co-authorship network
The 25 scholars most cited alongside R Eberl, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 3 | |
| 2 | 2006 | 4 | |
| 3 | 2006 | 5 | |
| 4 | 2005 | 5 | |
| 5 | 2003 | 9 | |
| 6 | 1993 | 19 | |
| 7 | 1990 | 1 | |
| 8 | 1988 | 2 | |
| 9 | 1987 | 4 | |
| 10 | 1987 | 1 | |
| 11 | [Determination of growth hormone in plasma of psoriatic arthritis, psoriasis vulgaris and seronegative spondylarthritis]. | 1986 | 1 |
| 12 | 1984 | 5 | |
| 13 | 1982 | 9 | |
| 14 | [Controlled double blind comparison of acemetacin to indomethacin in patients with chronic polyarthritis]. | 1980 | 1 |
| 15 | Leucocyte migration inhibition with collagen type I and collagen type III in rheumatoid arthritis and degenerative joint diseases. | 1978 | 18 |
| 16 | [Investigations on the plasm amino acids of old patients with rheumatoid arthritis (author's transl)]. | 1977 | 1 |
| 17 | 1976 | 53 | |
| 18 | [Sulindac: Clinical test of a new antiinflammatory agent in rheumatoid arthritis (author's transl)]. | 1976 | 2 |
| 19 | 1974 | 2 | |
| 20 | 1973 | 13 |
About R Eberl
R Eberl is a scholar working on Rheumatology, Pharmacology, Rehabilitation, Radiology, Nuclear Medicine and Imaging and Orthopedics and Sports Medicine, having authored 65 papers that have together received 314 indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (16 papers), Inflammatory mediators and NSAID effects (8 papers), Monoclonal and Polyclonal Antibodies Research (7 papers), Urticaria and Related Conditions (5 papers), Drug-Induced Adverse Reactions (4 papers), Spondyloarthritis Studies and Treatments (4 papers), Orthopedic Surgery and Rehabilitation (4 papers) and Systemic Lupus Erythematosus Research (4 papers). The work is most often cited by research in Rheumatology (108 citations), Immunology and Allergy (43 citations), Pharmacology (75 citations), Immunology (58 citations) and Molecular Medicine (13 citations). R Eberl has collaborated with scholars based in Austria, Germany and Switzerland. Frequent co-authors include C Steffen, Oliver Frank, G Partsch, N Thumb, G Kolarz, J Menzel, Josef Neumüller, Attila Dunky, Michael B. Fischer and J. R. Goulet. Their work appears in journals such as Advances in experimental medicine and biology, Der Unfallchirurg, Pathobiology, Scandinavian Journal of Rheumatology and Journal of Antimicrobial Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.